Camurati-Engelmann Disease Clinical Trials

Find Camurati-Engelmann Disease Clinical Trials Near You

Natural History and Genetics of Food Allergy and Related Conditions

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

Background: \- About 15 million Americans have a food allergy. Because there are no cures or effective prevention or treatment for food allergies, researchers want to learn more about them.

Objective: \- To learn more about the causes and effects of food allergy and related conditions.

Eligibility: * People ages 2 99 who have food allergy and/or a related genetic or other condition * Their relatives * Healthy relatives and volunteers

Design: * Participants will have at least 3 visits over 1 2 years, and then once a year for up to 12 years. Each may last a day or longer. * Participants will be screened with medical history, physical exam, and questionnaires. * Participants may have the following: * Blood tests * Allergy skin prick tests: Drops of allergens are placed on the back or arm. The skin is scratched under each drop. * Leukapheresis: blood is taken from a needle in one arm, passed through a machine, and returned through a needle in the other arm. * X-rays * Esophageal string test: One end of a string is taped to the cheek and the other end is packed into a capsule. When the capsule is swallowed, the string unwinds; it is left in for at least 1 hour. * EGD and colonoscopy: Biopsies are taken from the gastrointestinal system. * Tiny biopsies of skin * Photographs of the body * Collection of cells through: * Swab of nose, inside of cheek, or skin * Gentle skin scrape * Tape stripping: piece of tape is put on the skin and pulled off.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 1 day
Maximum Age: 99
Healthy Volunteers: t
View:

⁃ All participants must meet the following criteria:

• Be 2 to 99 years-old at the time of enrollment for participants who will be seen at the NIH CC; be 0 (newborn) to 99 years-old at the time of enrollment for participants who will submit mail-in samples or participate in telehealth visits. Only viable neonates will be enrolled.

• Willing to allow storage of blood, buccal swabs, saliva, nasal swabs, stool samples, and other clinically appropriate tissue specimens for future use in medical research

• Required to have a primary care or other physician who will manage all health conditions related or unrelated to the study objectives

⁃ ADDITIONAL INCLUSION CRITERIA FOR AFFECTED PARTICIPANTS

⁃ In addition to the general criteria listed above, affected participants must meet 1 of the following criteria:

• Have a clinical history of an immediate hypersensitivity reaction to food(s) and be sensitized to food allergen(s) (as evidenced by positive SPT or allergen-specific IgE testing)

• Be sensitized (as evidenced by positive SPT or allergen-specific IgE testing) to food allergen(s) but have no overt clinical history of IgE-mediated symptoms when they eat that food(s)

• Have a suspected genetic or congenital disorder potentially associated with food allergy or related condition, as determined by the principal investigator (PI) or associate investigators (AIs)

• Have a diagnosis of eosinophilic esophagitis (EoE), or clinical suspicion for EoE as determined by the principal investigator (PI) or associate investigators (AIs)

• Have a history of atopic dermatitis based on self-report or physician assessment.

⁃ ADDITIONAL INCLUSION CRITERIA FOR UNAFFECTED RELATIVES:

⁃ In addition to the general criteria listed above, unaffected relatives must meet the following criteria:

• Be a relative of an affected participant

• Be unaffected by food allergy (as determined by clinical history and/or allergy testing) or be unaffected by the genetic condition under study

⁃ ADDITIONAL INCLUSION CRITERIA FOR HEALTHY VOLUNTEERS

⁃ In addition to the general criteria listed above, healthy volunteers must meet the following criteria:

• Be unrelated to an affected participant

• Be unaffected by food allergy (as determined by clinical history and/or allergy testing) or be unaffected by the genetic condition under study

⁃ ADDITIONAL PROCEDURE- SPECIFIC INCLUSION CRITERIA:

⁃ The following additional inclusion criteria apply for participants undergoing leukapheresis:

• Age \>= 18 years

• Stable hematologic parameters (definition: white blood cell count \> 2,500/microL, hemoglobin \> 10 g/dL, and platelet count \> 75,000/microL)

Locations
United States
Maryland
National Institutes of Health Clinical Center
RECRUITING
Bethesda
Contact Information
Primary
Ellen Zektser, R.N.
niaidfars@niaid.nih.gov
Not Listed
Backup
Pamela A Frischmeyer-Guerrerio, M.D.
pamela.guerrerio@nih.gov
(301) 402-9782
Time Frame
Start Date: 2015-07-29
Estimated Completion Date: 2027-06-15
Participants
Target number of participants: 1800
Treatments
Affected Genetic
Have a suspected genetic or congenital disorder potentially associated with food allergy or related condition, as determined by the principal investigator (PI) or associate investigators (AIs).
Affected Non-Syndromic Food
Individuals with a clinical history of immediate hypersensitivity reaction to foods and sensitized to food allergen(s) as evidenced by SPT or allergen-specific IgE testing.
Allergic GI Disease
Individuals with a diagnosis or clinical suspicion of eosinophilic esophagitis (EoE), as determined by the principal investigator (PI) or associate investigators (AIs).
Unaffected Relative / Healthy Volunteer
Unaffected relatives are relatives of affected; unaffected by food allergy or the genetic condition under study. Healthy volunteers are not related to affected and serve as controls.
Authors
Pamela A Guerrerio
Sponsors
Leads: National Institute of Allergy and Infectious Diseases (NIAID)

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.